Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

LMAT Lemaitre Vascular Inc

Price (delayed)

$82.55

Market cap

$1.87B

P/E Ratio

40.87

Dividend/share

$0.72

EPS

$2.02

Enterprise value

$2.03B

LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, ...

Highlights
LMAT's quick ratio has soared by 164% YoY and by 27% QoQ
LMAT's net income is up by 33% year-on-year and by 2.6% since the previous quarter

Key stats

What are the main financial stats of LMAT
Market
Shares outstanding
22.59M
Market cap
$1.87B
Enterprise value
$2.03B
Valuations
Price to earnings (P/E)
40.87
Price to book (P/B)
5.36
Price to sales (P/S)
8.23
EV/EBIT
33.86
EV/EBITDA
29.07
EV/Sales
8.95
Earnings
Revenue
$226.26M
Gross profit
$155.66M
Operating income
$53.01M
Net income
$45.16M
EBIT
$59.81M
EBITDA
$69.65M
Free cash flow
$41.12M
Per share
EPS
$2.02
EPS diluted
$1.97
Free cash flow per share
$1.82
Book value per share
$15.41
Revenue per share
$10.02
TBVPS
$20.19
Balance sheet
Total assets
$556.01M
Total liabilities
$208.43M
Debt
$185.36M
Equity
$347.57M
Working capital
$383.37M
Liquidity
Debt to equity
0.53
Current ratio
16.49
Quick ratio
13.65
Net debt/EBITDA
2.3
Margins
EBITDA margin
30.8%
Gross margin
68.8%
Net margin
20%
Operating margin
23.4%
Efficiency
Return on assets
9.8%
Return on equity
13.5%
Return on invested capital
14.6%
Return on capital employed
11.3%
Return on sales
26.4%
Dividend
Dividend yield
0.87%
DPS
$0.72
Payout ratio
35.6%

LMAT stock price

How has the Lemaitre Vascular stock price performed over time
Intraday
-0.37%
1 week
1.9%
1 month
4.89%
1 year
6.63%
YTD
-10.41%
QTD
-1.61%

Financial performance

How have Lemaitre Vascular's revenue and profit performed over time
Revenue
$226.26M
Gross profit
$155.66M
Operating income
$53.01M
Net income
$45.16M
Gross margin
68.8%
Net margin
20%
LMAT's net income is up by 33% year-on-year and by 2.6% since the previous quarter
The operating income has grown by 30% YoY
The company's net margin rose by 18% YoY
The company's gross profit rose by 17% YoY and by 3.2% QoQ

Price vs fundamentals

How does LMAT's price correlate with its fundamentals

Growth

What is Lemaitre Vascular's growth rate over time

Valuation

What is Lemaitre Vascular stock price valuation
P/E
40.87
P/B
5.36
P/S
8.23
EV/EBIT
33.86
EV/EBITDA
29.07
EV/Sales
8.95
The EPS has grown by 32% YoY and by 3.1% from the previous quarter
The P/E is 12% less than the last 4 quarters average of 46.7 and 7% less than the 5-year quarterly average of 44.1
The equity has grown by 13% YoY and by 3% from the previous quarter
LMAT's price to book (P/B) is 12% higher than its 5-year quarterly average of 4.8 but 9% lower than its last 4 quarters average of 5.9
The P/S is 14% above the 5-year quarterly average of 7.2 but 10% below the last 4 quarters average of 9.1
Lemaitre Vascular's revenue has increased by 13% YoY and by 2.9% from the previous quarter

Efficiency

How efficient is Lemaitre Vascular business performance
LMAT's ROIC is down by 34% year-on-year and by 19% since the previous quarter
The ROS has grown by 19% YoY
The ROE has grown by 17% YoY
Lemaitre Vascular's return on assets has decreased by 8% QoQ and by 2% YoY

Dividends

What is LMAT's dividend history
DPS
$0.72
Dividend yield
0.87%
Payout ratio
35.6%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Lemaitre Vascular financials performed over time
The company's total assets is 167% higher than its total liabilities
LMAT's quick ratio has soared by 164% YoY and by 27% QoQ
Lemaitre Vascular's current ratio has soared by 118% YoY and by 25% from the previous quarter
The company's debt is 47% lower than its equity
The equity has grown by 13% YoY and by 3% from the previous quarter
Lemaitre Vascular's debt to equity has decreased by 3.6% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.